Q4 2021 Holdings
Filed 2022-02-14 | 97 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED | 04351P101 | $1.0B | 7,567,900 | 69.7% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $156.8M | 9,607,028 | 10.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $69.7M | 1,804,795 | 4.8% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $66.1M | 9,770,773 | 4.5% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $44.4M | 1,377,569 | 3.0% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $36.3M | 4,995,807 | 2.5% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $14.5M | 914,094 | 1.0% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $13.8M | 2,589,904 | 0.9% |
| CUE Health Inc(HLTHQ) | COM | 229790100 | $10.1M | 750,000 | 0.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.8M | 1,025,641 | 0.6% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $5.9M | 1,849,518 | 0.4% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $5.4M | 350,000 | 0.4% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $3.7M | 500,000 | 0.3% |
| Cvrx Inc(CVRX) | COM | 126638105 | $3.4M | 275,000 | 0.2% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $300.1K | 2,097,794 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $205.7K | 4,417,259 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $174.3K | 5,614,428 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $171.1K | 8,670,644 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $150.2K | 20,241,458 | 0.0% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $137.6K | 13,150,849 | 0.0% |
| Icosavax Inc | COM | 45114M109 | $132.2K | 5,779,347 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $131.8K | 5,208,911 | 0.0% |
| VOR Biopharma Inc | COM | 929033108 | $129.2K | 11,120,973 | 0.0% |
| Forma Therapeutics | SHS | 34633R104 | $128.1K | 9,011,651 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $101.8K | 7,236,454 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $100.9K | 4,240,464 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $98.0K | 6,103,594 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $97.4K | 8,263,982 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $86.0K | 5,605,129 | 0.0% |
| DAY One Biopharmaceuticals(DAWN) | COM | 23954D109 | $83.7K | 4,965,588 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $83.3K | 4,870,793 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $82.4K | 10,230,274 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $67.3K | 3,551,508 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $66.3K | 2,843,757 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $64.9K | 4,965,769 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $63.7K | 3,593,052 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $61.3K | 3,115,008 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $55.9K | 381,046 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $54.2K | 3,333,700 | 0.0% |
| Pardes Biosciences Inc | Com | 69945Q105 | $51.2K | 3,127,038 | 0.0% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $51.1K | 4,291,881 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $50.4K | 9,003,018 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $48.6K | 4,871,067 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $47.2K | 7,655,015 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $46.8K | 2,186,636 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $46.0K | 2,107,149 | 0.0% |
| Relmada Therapeutics(RLMD) | COM | 75955J402 | $45.1K | 2,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $42.0K | 2,210,145 | 0.0% |
| Eyepoint Pharmaceuticals(EYPT) | COM NEW | 30233G209 | $41.3K | 3,370,506 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $40.3K | 3,577,094 | 0.0% |